Amarantus Bioscience Holdings, Inc.

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2016-06-30

Quarterly Report for period ending 2016-03-31

Annual Report for period ending 2015-12-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2016-03-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2015-12-31

Quarterly Report for period ending 2015-09-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2015-09-30

Quarterly Report for period ending 2015-06-30

Quarterly Report for period ending 2015-03-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2015-03-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Exempt (Private) Offering

Notice of termination of registration of a class of securities under Section 12(g)

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

Post-effective amendment to a registration statement that is not immediately effective upon filing

Notice of Effectiveness

Notice of Effectiveness

Exempt (Private) Offering

Order Granting Confidential Treatment

Lorient Ventures Ltd: Major Shareholders

Anson Funds Management LP: Major Shareholders

Dominion Capital L.L.C.: Major Shareholders

Wei Rongguo: Statement of changes in beneficial ownership of securities

Flanigan Conn: Statement of changes in beneficial ownership of securities

TRAPP ROBERT H: Statement of changes in beneficial ownership of securities

Spence Steven: Initial statement of beneficial ownership of securities

TRAPP ROBERT H: Initial statement of beneficial ownership of securities

Flanigan Conn: Initial statement of beneficial ownership of securities

Wei Rongguo: Initial statement of beneficial ownership of securities

Withdrawal of offering statement under Regulation A

Offering statement under Regulation A

Offering statement under Regulation A

Offering statement under Regulation A

Non-public draft offering statement under Regulation A

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Preliminary revised proxy soliciting materials

Preliminary revised proxy soliciting materials

Preliminary proxy statement not related to a contested matter or merger/acquisition

Preliminary revised proxy soliciting materials

Preliminary revised proxy soliciting materials

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.